Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Hedenfalk

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|June 9, 2019
Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltrationSvenja Offer, Julien A Menard, Julio Enríquez Pérez, et al.
Nature Communications|April 9, 2024
Molecular patterns of resistance to immune checkpoint blockade in melanomaMartin Lauss, Bengt Phung, Troels Holz Borch, et al.
Frontiers in Immunology|July 5, 2023
Breast cancer associated CD169<sup>+</sup> macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cellsFrida Björk Gunnarsdottir, Oscar Briem, Aida Yifter Lindgren, et al.
Gynecologic Oncology|February 6, 2025
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell densitySara Corvigno, Josefin Fernebro, Josefin Severin Karlsson, et al.
Springerplus|April 6, 2013
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancerCarina Strand, Martin Bak, Signe Borgquist, et al.
Breast Cancer Research : BCR|February 19, 2021
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancerKamila Kaminska, Nina Akrap, Johan Staaf, et al.
Cancer Cell|November 15, 2017
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor ProgressionAsis Palazon, Petros A Tyrakis, David Macias, et al.
Nature Communications|May 7, 2024
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancerKang Wang, Ioannis Zerdes, Henrik J Johansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast CancerSiker Kimbung, Ida Johansson, Anna Danielsson, et al.
Breast Cancer Research : BCR|October 15, 2017
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control studyKatherine Lawler, Efterpi Papouli, Cristina Naceur-Lombardelli, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Experimental & Clinical Cancer Research : CR|June 9, 2019
Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltrationSvenja Offer, Julien A Menard, Julio Enríquez Pérez, et al.
Nature Communications|April 9, 2024
Molecular patterns of resistance to immune checkpoint blockade in melanomaMartin Lauss, Bengt Phung, Troels Holz Borch, et al.
Frontiers in Immunology|July 5, 2023
Breast cancer associated CD169<sup>+</sup> macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cellsFrida Björk Gunnarsdottir, Oscar Briem, Aida Yifter Lindgren, et al.
Gynecologic Oncology|February 6, 2025
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell densitySara Corvigno, Josefin Fernebro, Josefin Severin Karlsson, et al.
Springerplus|April 6, 2013
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancerCarina Strand, Martin Bak, Signe Borgquist, et al.
Breast Cancer Research : BCR|February 19, 2021
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancerKamila Kaminska, Nina Akrap, Johan Staaf, et al.
Cancer Cell|November 15, 2017
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor ProgressionAsis Palazon, Petros A Tyrakis, David Macias, et al.
Nature Communications|May 7, 2024
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancerKang Wang, Ioannis Zerdes, Henrik J Johansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast CancerSiker Kimbung, Ida Johansson, Anna Danielsson, et al.
Breast Cancer Research : BCR|October 15, 2017
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control studyKatherine Lawler, Efterpi Papouli, Cristina Naceur-Lombardelli, et al.
Pageof 7